- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07255586
Self-monitoring of Hearing Aids Using Artificial Intelligence
Study Overview
Status
Conditions
Detailed Description
Considering the growing population, healthcare is increasingly focusing on integrating digital solutions into care. Such solutions typically require active patient participation and have the potential to positively impact person-centered care.
The purpose of this project is to investigate the outcomes of complementing physical and/or digital hearing care visits with patient self-monitoring of hearing aids. Participants will undergo the standard steps of the hearing rehabilitation process. In addition, the intervention group will be offered the opportunity to self-monitor their hearing aids between physical and/or digital appointments using artificial intelligence (AI) integrated into a mobile application provided by a hearing aid supplier.
The focus is to increase patient involvement in the rehabilitation process, utilize adjustment possibilities in everyday sound environments, and improve access to hearing care for the target population.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Milijana M Malmberg, PhD
- Phone Number: +46703803663
- Email: milijana.lundberg.malmberg@vgregion.se
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Individuals who are eligible for a new or renewed hearing rehabilitation process at four of the Hearing organizations audiology clinics
Exclusion Criteria:
- Not fullfilling the inclusion criteria
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention group
Self-monitoring of hearing aids.
ALl participants in this group are offered self-monitoring of hearing aids.
|
Self-monitoring of hearing aids using artificial intelligence
|
|
Other: Standard care
All participants in this group are offered traditional hearing care.
|
Traditional hearing care at our clinics
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hearing Handicap Inventory for the Elderly-Screening
Time Frame: From enrollment to the end of treatment at 6 months
|
Evaluates self-perceived psychosocial and emotional effects of hearing loss.
Min 0 to max 100 points.
Higher points equal greater self-perceived hearing problems.
|
From enrollment to the end of treatment at 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Client Oriented Scale of Improvement
Time Frame: From enrollment to the end of treatment at 6 months
|
Not reporting score on a scale.
|
From enrollment to the end of treatment at 6 months
|
|
Communication Strategies Scale of the Communication Profile for the Hearing Impaired
Time Frame: From enrollment to the end of treatment at 6 months
|
The CSS includes three subscales: the Maladaptive Behaviours, nine questions addressing strategies that complicate communication, and Verbal Strategies and Nonverbal Strategies, both of which address 16 items related to strategies that can improve communication.
The scoring for all three subscales reflects how frequently a specific strategy occurs in different situations.
|
From enrollment to the end of treatment at 6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
International Outcome Inventory for Hearing Aids
Time Frame: At the end of treatment at 6 months
|
The IOI-HA measures seven different variables where higher points equal better outcomes.
The variables are use, benefit, activity limitation, satisfaction, participation restriction, impact on environment, and quality of life.
|
At the end of treatment at 6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Milijana M Malmberg, PhD, Habilitering & Hälsa
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Self-monitoring of HAs
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hearing Loss
-
MED-EL Elektromedizinische Geräte GesmbHCompletedHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Unilateral | Hearing Loss, MixedAustria, Germany, United Kingdom
-
Oticon MedicalCompletedEar Diseases | Hearing Loss, Conductive | Hearing Loss Mixed | Hearing Disability | Conductive Hearing Loss | Conductive Hearing Loss, Bilateral | Conductive Hearing Loss, UnilateralUnited Kingdom
-
Oticon MedicalNot yet recruitingSensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound
-
Manchester University NHS Foundation TrustUniversity of ManchesterCompletedCochlear Hearing Loss | Sensorineural Hearing Loss, BilateralUnited Kingdom
-
Truway Health, Inc.Enrolling by invitationSensorineural Hearing Loss | Tinnitus | Sudden Hearing Loss | Acoustic Trauma | Inner Ear Injury | Noise-Induced Hearing Loss | Vestibular DysfunctionUnited States
-
University of California, San FranciscoPatient-Centered Outcomes Research InstituteRecruitingHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Noise-Induced | Hearing Loss, Unilateral | Hearing Loss, Mixed | Hearing Disorders in ChildrenUnited States
-
Envoy Medical CorporationActive, not recruitingSensorineural Hearing Loss | Sensorineural Hearing Loss (Disorder) | Sensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound | Sensori-Neural DeafnessUnited States
-
Oticon MedicalCompletedConductive Hearing Loss | Conductive and Sensori-neural Hearing Loss in the Same Ear | Unilateral, Profound Sensori-neural Hearing LossUnited States
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Presbycusis | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
Clinical Trials on Self-monitoring of hearing aids using artificial intelligence
-
JOSE FERNANDO VILELA-MARTINEnrolling by invitation
-
Sonova AGSonova Audiological Care Australia Pty LtdCompletedHearing LossAustralia
-
Seoul National University HospitalUnknownNon-cardiac SurgeryKorea, Republic of
-
Nigde Omer Halisdemir UniversityCompletedSurgical Anxiety Scale for Adult Patients | Surgical Fear Scale | Postpartum Comfort ScaleTurkey (Türkiye)
-
International Centre for Diarrhoeal Disease Research...Bill and Melinda Gates Foundation; Salu Design GroupRecruitingHypertension, Pregnancy-Induced | Hypertension in Pregnancy | Hypertension, Essential Hypertension | Hypertension; Pre-EclampsiaBangladesh
-
University Hospital, Clermont-FerrandRecruitingHealthy Control | Necrotizing Enterocolitis (NEC)France
-
Centre hospitalier de l'Université de Montréal...DIAGNOS Inc.RecruitingDiabetic Retinopathy | Diabetic Macular Edema | Diabetic MaculopathyCanada
-
Capital Medical UniversityMerck Sharp & Dohme LLCRecruitingSchizophrenia | Metabolic Syndrome | Bipolar Disorder | Overweight and ObesityChina
-
Instituto Ecuatoriano de Enfermedades DigestivasRecruitingAbdomen | Mediastinum | Anatomic Abnormality | StricturesEcuador
-
Jaeb Center for Health ResearchActive, not recruitingCystic FibrosisUnited States